{"nct_id":"NCT03062358","title":"Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2017-04-27","start_date_type":"ACTUAL","primary_completion_date":"2021-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}